Quadri Meningo Vaccine

MENINGOCOCCAL POLYSACCHARIDE VACCINE (Group A, C, Y & W135) I.P. Quadri Meningo^TM

Polysaccharide vaccine against cerebrospinal meningitis caused by Neisseria meningitides Group A, C, Y &W135. Quadri Meningo^TM fulfils the specification of Meningococcal Polysaccharide Vaccine as given in Indian Pharmacopoeia. The manufacturing facilities meets the requirements of cGMP guidelines of revised schedule ‘M’ of Government of India.

INDICATIONS

Prevention of cerebrospinal meningitis caused by Neisseria meningitides Group A, C, Y & W135. Vaccination is recommended in regions of endemic infection, travellers to countries with epidemic meningococcal disease (Haji pilgrims), household or institutional contacts, military recruits. It is also recommended for subjects living in closed communities and close contact of patients/carriers of Meningococcal Group A, C, Y & W135.

COMPOSITION

Each dose (0.5 ml) of vaccine contains:

Purified Polysaccharide of Neisseria meningitidis

-Group A……………………………………………………………………………………………50 µg

-Group C……………………………………………………………………………………………50 µg

-Group Y……………………………………………………………………………………………50 µg

-Group W135………………..……………………………..……………………………………50 µg

Lactose I.P. (Stabilizer) ………………………….……………………………….…5 mg

Thimerosal I.P. (Preservative) ……….………………………………………….……0.05 mg

PACK SIZE

One, five and ten dose in glass vial with appropriate diluents.